AD, Market Access Strategy

Benefits

Additional Information

Why Join Intellia? Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done. We want all of our people to go beyond what is possible. We aren't constrained by typical end rails, and we aren't out to just "treat" people. We're all in this for something more. We're driven to cure and motivated for change. Just imagine the possibilities of what we can do together. Intellia Therapeutics, a pioneer in gene editing, is preparing to launch its first gene editing therapies, with a focus on groundbreaking treatments for rare and serious diseases, including hereditary angioedema (HAE) and transthyretin amyloidosis (ATTR). We are seeking an experienced Associate Director of Market Access Strategy to support our strategic and tactical efforts in demonstrating the value of, and facilitating the adoption of our late-stage asset for ATTR. This role is critical to ensuring successful product launch, fostering market access, site readiness, and building a compelling narrative that resonates with diverse stakeholders, from healthcare providers, channel partners, and payers to patients and caregivers. This role will primarily support launch activities for ATTR, with secondary responsibilities for supporting the portfolio, global market access workstreams, and pipeline. Duties/Responsibilities Access & Value Strategy Development: Support the creation and execution of comprehensive market access & value strategies that clearly communicate the impact and benefits of Intellia's gene editing therapies in ATTR. Contribute to and refine strategies that align with our US and global commercial goals and resonate in global markets. Stakeholder Communication: Develop clear and persuasive communication plans that effectively convey the differentiated value proposition of our therapies for US and global stakeholders. Partner with cross-functional teams, including market access, HEOR, marketing, medical affairs, and corporate communications, to craft narratives that address the needs and interests of clinicians, payers, channel partners, and patient advocacy groups. Supports identification of evidence enhancements & gaps to inform future research objectives to bolster the value proposition and to support product positioning and aligned access goals. Launch & Site Readiness: Develop and refine launch plans and lead execution of US and global market access strategies, marketing initiatives and corresponding materials/ innovative tactics to ensure launch readiness across all access channels to secure access for providers and patients. Market development: Work to establish reimbursement pathways for first-in-class gene therapies across access stakeholders including payer pre-launch engagement plans and site readiness preparation, including supporting marketing programs and communication materials. Market Insights & Competitive Intelligence: Leverage insights from the ATTR access & payer landscapes to inform value strategy, messaging, and positioning. Regularly analyze market trends, competitive activity, and regulatory landscape to refine Intellia's approach and enhance the launch trajectory. Assess the impact of key policies to the portfolio (e.g. IRA, MFN, etc) Pricing & Reimbursement Strategy Support : Collaborate with market access and HEOR teams to help shape pricing and reimbursement strategies for US and global markets leveraging a understanding of gene therapy valuation models. Develop arguments, evidence frameworks and communication materials to support optimal coverage and reimbursement, particularly for novel therapies in rare disease. Cross-Functional C ollaboration : Lead cross-functional initiatives with internal stakeholders to ensure cohesive launch readiness. Serve as a key contributor to strategic communications efforts related to product value, bridging scientific, commercial, and patient-oriented teams to create unified messages. Effectively leads cross-functionally, particularly across Market Access, HEOR, Brand, Regulatory, and Medical to ensure alignment around, and delivery against, access goals and ensures access view is represented in commercial and development plans, and forecasts. P ortfolio Support: Provide support for portfolio and pipeline Market Access related activities including, but not limited to global access strategy, payer marketing workstreams, market insights and analytics, congress engagement, secondary research and analyses. Re

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at intelliatx? Share your experience